MSMatthew Sherman

Matthew Sherman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Matthew Sherman has a total of 106 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Medium term reoperation rates after primary total elbow arthroplasty at a single institution: 303 cases

    by Akash Singh, Miguel Fiandeiro, James Satalich, Brendan Shi, Caroline Markmann, Harrison Fellheimer, Max Kunz, Matthew Sherman, Matthew Ramsey, Surena Namdari

  • Are Social Determinants of Health Disparities Associated With Worse Completion Rates for Patient-reported Outcome Measures After Total Joint Arthroplasty?

    by Samantha Meacock, Alexandra Hohmann, Mason T. Sellig, Matthew Sherman, Yale A. Fillingham

    Background: Patient-reported outcome measures (PROMs) are important markers to assess patient improvement after total joint arthroplasty (TJA). PROMs are increasingly relevant because of new PROM-reporting requirements for elective inpatient TJA from the Centers for Medicare & Medicaid Services. Social determinants of health (SDOH) disparities have been associated with various worse outcomes after TJA, but to our knowledge, it is not yet known how PROM completion may be affected by SDOH disparities. Questions/purposes: Among patients undergoing TJA, (1) are there SDOH disparities (such as insurance, transportation access, and living alone) that are associated with differences in PROM completion? (2) Are there neighborhood metrics, including Social Vulnerability Index (SVI) and the Area Deprivation Index (ADI), that are associated with differences in PROM completion? Methods: This study was a retrospective, comparative single-institution study of 12,842 patients who underwent primary, unilateral TJA for osteoarthritis between 2019 and 2022. Study participants had a mean ± SD age of 67 ± 10 years, 45% (5745) were men, and 86% (10,131 of 11,833) were White. Mean ± SD national ADI score was 34 ± 21, and SVI score was 0.4 ± 0.3. PROMs were collected within the first year preoperatively and at 6 months, 1 year, and 2 years postoperatively per institutional protocol. Patient demographic and socioeconomic factors were collected from the institutional medical record. We examined whether PROM noncompletion and completion differed in terms of SDOH, including living alone, transportation access, and insurance type. Race and ethnicity were self-reported by patients. We additionally examined whether PROM noncompletion and completion differed in terms of neighborhood metrics including SVI and ADI scores. For proportions, a clinically important difference was defined by a 15% change. Results: We found no clinically important differences regarding SDOH disparities in terms of PROM noncompletion and completion; specifically, there were no differences in PROM completion based on Black race (preoperative: 13% [312 of 2332] versus 9% [884 of 9501]; p < 0.001; 1 year: 11% [886 of 8015] versus 8% [310 of 3818]; p < 0.001), lack of transportation access (preoperative: 3% [67 of 2002] versus 2% [199 of 8494]; p = 0.01; 1 year: 3% [205 of 7050] versus 2% [61 of 3446]; p = 0.001), living alone (preoperative: 23% [466 of 1988] versus 21% [1750 of 8452]; p = 0.01; 1 year: 23% [1577 of 6999] versus 19% [639 of 3441]; p < 0.001), and commercial insurance preoperatively (62% [1577 of 2563] versus 65% [6675 of 10,279]; p < 0.001). For neighborhood-level metrics, we found no clinically important difference for PROM noncompletion and completion in terms of mean ± SD ADI scores nationally (preoperative: 36 ± 23 versus 34 ± 21; p = 0.004; 1 year: 39 ± 21 versus 33 ± 20; p < 0.001) and SVI scores (preoperative: 0.4 ± 0.3 versus 0.4 ± 0.3, mean difference 0.1 [95% CI 0.53 to 0.73]; p < 0.001; 1 year: 0.4 ± 0.3 versus 0.4 ± 0.3, mean difference 0.1 [95% CI 0.61 to 0.80]; p < 0.001). Conclusion: No clinically important difference was found for various SDOH disparities and neighborhood metrics investigated in this study. Considering these findings, lack of transportation access, living alone, race, insurance type, and address-related neighborhood disadvantage may not be strong indicators of PROM completion after TJA. However, SDOH disparities still require further investigation to understand the relationship between other SDOH disparities and different populations outside of our urban institution. Level of Evidence: Level III, prognostic study.

  • Radiographic Measures of Patellar Tracking After Total Knee Arthroplasty: Comparing the Native Patellar Midpoint Versus Median Ridge as Reference Landmarks

    by Mason T. Sellig, Jessica H. Leipman, Hannah D. Bash, Matthew B. Sherman, Camilo Restrepo, Jess H. Lonner

  • Higher Area Deprivation Index Is Associated With Greater Practice-initiated Perioperative Communication Workload in Patients With Primary Total Joint Arthroplasty

    by Alan David Lam, Jessica H. Leipman, Samantha S. Meacock, Nihir Parikh, Matthew B. Sherman, Yale A. Fillingham, Chad A. Krueger

    Background: Although deficits in social determinants of health (SDOH) have been previously associated with adverse clinical outcomes after primary THA and TKA, their role in the perioperative communication workload remains poorly characterized. Even though it remains essential to appropriately identify and address modifiable SDOH before a procedure, orthopaedic practices must also have the resources to handle the coordination of care effectively. Understanding how deficiencies in SDOH can impact communication workload would help support effective resource planning and equitable patient engagement strategies, particularly as more perioperative management takes place outside the hospital setting. Questions/purposes: (1) What are the differences in touchpoint utilization in patients who live in locations with varying Area Deprivation Index (ADI) scores, a surrogate measure for social deprivation? (2) Does social deprivation have an association with the length of stay (LOS) during primary total joint arthroplasty? (3) How are readmission rates and patient-reported outcome measures (PROMs) different in patients living in areas with varying degrees of social deprivation? Methods: In this retrospective, comparative study, there were 92,801 patients who underwent primary, elective THA (43% [39,963]) or TKA (57% [52,837]) for osteoarthritis at one high-volume, urban, academic institution between January 2016 and December 2022. Of those, exclusions consisted of indications other than osteoarthritis (2% [1595]), no available ADI data (13% [12,302]), or loss to minimum 90-day postoperative follow-up and incomplete data (29% [26,836]). In all, 52,068 patients were included in the final analysis, with 43% (22,363) of patients undergoing primary THA and 57% (29,705) undergoing primary TKA. To determine the degree of social deprivation, the 2022 ADI was used and linked to patients’ street addresses. Using the ADI national ranking from 1 to 100, with 1 representing the lowest level of disadvantage and 100 representing the highest level of disadvantage, patients were compared by ADI quartiles; Quartile 1 represented the least disadvantaged cohort and Quartile 4 represented the most disadvantaged cohort. Overall, the mean ± SD age was 66 ± 10 years, and the population consisted of 56% (29,333 of 52,068) women. Thirty-three percent (17,391 of 52,068) of patients were in ADI Quartile 1, 44% (22,944 of 52,068) were in Quartile 2, 17% (8650 of 52,068) were in Quartile 3, and 6% (3083 of 52,068) were in Quartile 4. The primary outcome measure was the number of touchpoints per patient, defined as the communication points (telephone or electronic messages) sent or received on behalf of the patient in relation to the total joint arthroplasty procedure. Touchpoints within the 30-day preoperative or 90-day postoperative periods of the primary THA or TKA were included. Secondary outcome measures included LOS, 90-day readmissions, and PROMs consisting of the Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, JR) and the Hip Disability and Osteoarthritis Outcome Score for Joint Replacement (HOOS, JR). Changes in HOOS, JR and KOOS, JR scores were obtained for 34% (7627 of 22,363) and 35% (10,418 of 29,705) of patients who received THA and TKA, respectively. Unadjusted and adjusted binomial regression models were performed to assess the association of ADI quartiles with touchpoint quantity, assessed by whether touchpoints were incoming or outgoing. Results: After adjusting for age, gender, BMI, race and ethnicity, and year of surgery, the proportion of outgoing, staff-initiated touchpoints increased as the degree of social deprivation increased. Patients in ADI Quartile 4 demonstrated the greatest increase in outgoing touchpoints compared with Quartile 1 (incidence rate ratio [IRR] 1.17 [95% confidence interval (CI) 1.11 to 1.25]; p < 0.001). For every 100 touchpoints sent out to patients in Quartile 1, approximately 117 were sent to patients in Quartile 4. However, Quartile 4 had the lowest rate of incoming touchpoints compared with Quartile 1 (IRR 0.95 [95% CI 0.91 to 0.99]; p = 0.01). This translates to roughly 95 touchpoints received from patients in the most disadvantaged quartile for every 100 touchpoints received from patients in the least disadvantaged quartile. The mean ± SD LOS for primary total joint arthroplasty among patients in Quartile 4 was 1.7 ± 1.4 days, whereas patients in Quartile 1 had a mean LOS of 1.2 ± 1.0 days (p < 0.001). There was a stepwise decline in same-day discharge and LOS < 24 hours as the level of deprivation became more severe (p < 0.001). Patients in Quartile 4 were discharged the same day at lower rates compared with patients in Quartile 1 (7% [138 of 1894] versus 14% [1526 of 10,623]; p < 0.001). Patients in Quartile 4 had higher 90-day readmission rates at 4% (111 of 3083), whereas those in Quartile 1 had the lowest readmission rates at 3% (460 of 17,391) (p = 0.004). Similarly, readmission rates increased progressively as the level of deprivation became more severe. From those who completed preoperative and postoperative PROMs, the proportion of patients who achieved the minimum clinically important difference at 12 months did not differ across ADI quartiles for the KOOS, JR (p = 0.32) and the HOOS, JR (p = 0.67). Conclusion: While the magnitude of the differences in outgoing and incoming touchpoints between ADI quartiles was modest, the differences point to consistent patterns that practices can use to inform equity-based resource allocation and targeted patient engagement strategies. Orthopaedic surgeons may consider neighborhood-level deprivation indices to anticipate communication needs and perioperative support. Targeting barriers to care before they impede postoperative care is essential for patients from more disadvantaged areas. This can be achieved through flexible preoperative education via...


  • Mini-open Femoroacetabular Osteoplasty in Patients With Tönnis Grade 2 or Higher Osteoarthritis is Associated With a Higher Risk of Subsequent Conversion to THA

    by Mohammad S. Abdelaal, Ryan M. Sutton, Matthew B. Bs Sherman, Javad Md Parvizi

    Background: The severity of degenerative changes of the hip is known to adversely impact the outcomes of the treatment of femoroacetabular impingement (FAI). Although the operative indications for FAI have expanded to include patients with moderate degrees of hip osteoarthritis, the exact stage of hip osteoarthritis at which surgery for FAI can offer clinical benefits is still uncertain. Questions/purposes: (1) How does the survivorship free from conversion to THA and survivorship free from revision differ between patients with preexisting Tönnis Grades 2 or 3 changes and those without advanced degenerative changes (Tönnis Grade 0 or 1) after mini-open femoroacetabular osteoplasty? (2) What are the differences in hip-specific and general health outcome scores between the two groups after mini-open femoroacetabular osteoplasty? Methods: From December 2003 to April 2019, we treated 901 patients for FAI, and their clinical data were systematically recorded in a longitudinally maintained database. Mini-open femoroacetabular osteoplasty was our preferred surgical approach because of the surgeon's extensive experience with the technique. Among the entire dataset, 6% of patients (51 individuals) had Tönnis Grade 2 or higher hip osteoarthritis, while the remaining 94% (850 patients) had no or mild degenerative changes (Tönnis Grade 0 or 1). In the Tönnis Grade 2 or 3 group, three patients were lost before the minimum 2-year follow-up duration, leaving 4% (48 patients) who qualified for inclusion in the study. For the matched group with Tönnis Grade 0 or 1, 5% (45 patients) were excluded because of incomplete data, and a further 7% (58 patients) were excluded because they did not have 2 years of follow-up, leaving 83% (747 patients) who were eligible for the matching process. Matching was based on patient age (within 1 year), gender, and BMI (within one unit). Matching resulted in the inclusion of 144 randomly selected control patients in this retrospective, comparative study. General indications for femoroacetabular osteoplasty included symptoms of pain and restricted hip motion in young, active patients with signs of FAI evident on physical examination and radiographs. Patient demographics, medical history, radiographic parameters, and intraoperative findings were compared between the two groups to establish baseline differences and identify potential confounding variables. There was no difference in the mean ± standard deviation age between the cohort of interest and control group (39 ± 10 years and 38 ± 11 years, respectively; p = 0.67). There was no difference in the mean follow-up duration (7 ± 3 years versus 8 ± 2 years; p = 0.25) or the preoperative symptomatic period between the study and control groups (2 ± 2 years versus 3 ± 6 years; p = 0.09). There was no difference in the prevalence of dysplasia, slipped capital femoral epiphysis, Perthes disease, or avascular necrosis of the hip between the two groups. Intraoperatively, the groups did not differ in terms of labral repair (65% [31 of 48] versus 78% [113 of 144]; p = 0.08) and labral transplantation (2%; p > 0.99 for both); however, labral resection was performed more frequently in the study group (63% [30 of 48] versus 42% [60 of 144]; p = 0.002). At a minimum of 2 years of follow-up, survivorship free from conversion to THA and survivorship free from revision surgeries, as well as the latest clinical and functional outcome scores (SF-36, Hip Disability and Osteoarthritis Outcome Score, and modified Harris hip score), were compared between groups. Results: Survivorship free from conversion to THA at 5 years was lower among patients with preexisting Tönnis Grades 2 or 3 changes than it was among patients matched for age, gender, and BMI who did not have advanced degenerative changes (Tönnis Grade 0 or 1) after mini-open femoroacetabular osteoplasty (75% [95% confidence interval 64% to 88%] versus 92% [95% CI 87% to 96%]; p < 0.001). No patients in either group underwent reoperation other than conversion to THA. Although the groups did not differ at baseline in terms of their outcomes scores, the group with more visible arthritis had lower postoperative Hip Disability and Osteoarthritis Outcome Scores than the control group (60 ± 21 points versus 86 ± 11 points, mean difference 26 points [95% CI 10 to 41]; p =0.004). There were no other between-group differences in outcome scores after surgery. Conclusion: In our study, approximately 25% of patients undergoing mini-open femoroacetabular osteoplasty with Tönnis Grade 2 or higher osteoarthritis underwent conversion to THA within 5 years. Some postoperative functional scores were lower in patients with advanced arthritis than in matched patients with no or mild arthritis. We emphasize the importance of exercising caution when considering femoroacetabular osteoplasty in patients in whom advanced arthritis is already evident at the time of presentation. Level of Evidence: Level III, therapeutic study.


  • Procedures employing interbody devices and multi-level fusion require target price adjustment to build a sustainable lumbar fusion bundled payment model

    by Mark J. Lambrechts, Tariq Z. Issa, Yunsoo Lee, Nicholas D. D'ANtonio, Andrew Kalra, Matthew Sherman, Jose A. Canseco, Alan S. Hilibrand, Alexander R. Vaccaro, Gregory D. Schroeder, et al.


  • Predictors of Blood Transfusion in Patients Undergoing Lumbar Spinal Fusion

    by Jeremy C. Heard, Nicholas Siegel, Goutham R. Yalla, Mark J. Lambrechts, Yunsoo Lee, Matthew Sherman, Jasmine Wang, Julia Dambly, Sydney Baker, Grace Bowen, et al.


  • Distressed communities demonstrate increased readmission and health care utilization following shoulder arthroplasty

    by Dominic M. Farronato, Joshua D. Pezzulo, Alexander J. Rondon, Matthew B. Sherman, Daniel E. Davis


  • Risk stratification of patients undergoing outpatient lumbar decompression surgery

    by Jose A. Canseco, Brian A. Karamian, Mark J. Lambrechts, Tariq Z. Issa, William Conaway, Paul D. Minetos, Daniel Bowles, Tyler Alexander, Matthew Sherman, Gregory D. Schroeder, et al.


  • Factors associated with functional improvement after posteriorly augmented total shoulder arthroplasty

    by Michael J. Gutman, Eitan M. Kohan, Benjamin A. Hendy, Christopher D. Joyce, Jacob M. Kirsch, Arjun Singh, Matthew Sherman, Luke S. Austin, Surena Namdari, Gerald R. Williams